That's tame. It's a valid point that NWBO received PIM in Sept and still has not been approved for EAM yet Keytruda received PIM in Oct and is approved first.
I'd buy NWBO after reading about Keytruda in AF's TheStreet article. Thanks to AF for the tip and publicity. The fact that he mentions DCVax in the UK Early Access and in the German Health Exemption programs awaiting finality is actually a very good thing. After reading, I'd do my research and I'm sure I would buy, had I never heard much about the company.